Food intake is inhibited by oral oleoylethanolamide Published, JLR Papers in Press, April 1, 2004. DOI 10.1194/jlr.C300008-JLR200

Oleoylethanolamide (OEA) may be an endogenous regulator of food intake, and intraperitoneal injection of this compound decreases food intake in 24 h-starved rats (Rodriguez de Fonseca, F., M. Navarro, R. Gómez, L. Escuredo, F. Nava, J. Fu, E. Murillo-Rodríguez, A. Giuffrida, J. LoVerme, S. Gaetani, S. Kathuria, C. Gall, and D. Piomelli. 2001. An anorexic lipid mediator regulated by feeding. Nature. 414: 209–212). It is generally believed that this kind of lipid amide is rapidly catabolized in the gastrointestinal tract, thereby preventing its use as an oral antiobesity compound. We now show that oral OEA inhibits food intake dose dependently at 90 min after food presentation to starved rats. Food intake was reduced by 15.5% (P < 0.01) by administration of 10 mg/kg OEA. [3H]OEA was used to assess the degree of catabolism in the gastrointestinal tract. The endogenous level of this acylethanolamide was increased 11 times in the intestinal tissue (to 3.91 ± 0.98 nmol/g tissue, mean ± SEM) at 90 min after food presentation, based on the finding of 0.48% of the dose as intact OEA. These findings reveal unexpected properties of orally administered OEA, which may have potential as a cheap and safe antiobesity drug.

[1]  A. Randich,et al.  Suppression of food intake, body weight, and body fat by jejunal fatty acid infusions. , 2000, American journal of physiology. Regulatory, integrative and comparative physiology.

[2]  M. Chiesi,et al.  Pharmacotherapy of obesity: targets and perspectives. , 2001, Trends in pharmacological sciences.

[3]  H. Schmid,et al.  Properties of rat liver N-acylethanolamine amidohydrolase. , 1985, The Journal of biological chemistry.

[4]  S. Gaetani,et al.  Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α , 2003, Nature.

[5]  S. Gaetani,et al.  An anorexic lipid mediator regulated by feeding , 2001, Nature.

[6]  L. Lauritzen,et al.  Characterization of Glutamate‐Induced Formation of N‐Acylphosphatidylethanolamine and N‐Acylethanolamine in Cultured Neocortical Neurons , 1997, Journal of neurochemistry.

[7]  L. Parsons,et al.  Dopamine activation of endogenous cannabinoid signaling in dorsal striatum , 1999, Nature Neuroscience.

[8]  B. Swinburn,et al.  Preventive strategies against weight gain and obesity , 2002, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[9]  H. Schmid,et al.  N-acylated glycerophospholipids and their derivatives. , 1990, Progress in lipid research.

[10]  S. O’Rahilly,et al.  Obesity therapy: altering the energy intake-and-expenditure balance sheet , 2002, Nature Reviews Drug Discovery.

[11]  N. Read,et al.  The effects of intestinal infusion of long-chain fatty acids on food intake in humans. , 2000, Gastroenterology.

[12]  H. Hansen,et al.  N-Acylethanolamines and precursor phospholipids - relation to cell injury. , 2000, Chemistry and physics of lipids.

[13]  S. Yamamoto,et al.  Distribution of anandamide amidohydrolase in rat tissues with special reference to small intestine. , 1997, Biochimica et biophysica acta.

[14]  M. Palkovits,et al.  Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat , 1996, FEBS letters.

[15]  L. Wold,et al.  Anandamide and other N-acylethanolamines in human tumors , 2002, Lipids.

[16]  B. Cravatt,et al.  The enzymatic inactivation of the fatty acid amide class of signaling lipids. , 2002, Chemistry and physics of lipids.

[17]  S. Gaetani,et al.  Modulation of Meal Pattern in the Rat by the Anorexic Lipid Mediator Oleoylethanolamide , 2003, Neuropsychopharmacology.